Commonwealth Equity Services
AXSM icon

Commonwealth Equity Services’s Axsome Therapeutics AXSM Stock Holding History

Commonwealth Equity Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Buy
2,440
+781
+47% +$169K ﹤0.01% 3166
2026
Q1 		$280K Buy
1,659
+137
+9% +$23.7K ﹤0.01% 3696
2025
Q4 		$278K Buy
+1,522
New +$212K ﹤0.01% 3712
2024
Q1 		– Sell
-7,041
Closed -$560K – 4026
2023
Q4 		$560K Buy
7,041
+300
+4% +$20.1K ﹤0.01% 2605
2023
Q3 		$471K Buy
6,741
+1,558
+30% +$116K ﹤0.01% 2650
2023
Q2 		$372K Buy
+5,183
New +$382K ﹤0.01% 2856
2023
Q1 		– Sell
-9,624
Closed -$742K – 3779
2022
Q4 		$742K Sell
9,624
-576
-6% -$34.4K ﹤0.01% 2153
2022
Q3 		$455K Sell
10,200
-1,473
-13% -$73.6K ﹤0.01% 2486
2022
Q2 		$447K Sell
11,673
-1,318
-10% -$41.7K ﹤0.01% 2489
2022
Q1 		$537K Sell
12,991
-3,993
-24% -$124K ﹤0.01% 2462
2021
Q4 		$641K Buy
16,984
+2,079
+14% +$76.5K ﹤0.01% 2323
2021
Q3 		$491K Buy
+14,905
New +$581K ﹤0.01% 2483

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Commonwealth Equity Services's AXSM Position: Q2 2026 in Review

Commonwealth Equity Services increased its Axsome Therapeutics (AXSM) stake by 47% in Q2 2026, buying an estimated $169K and bringing the position to 2,440 shares worth $597K. The position accounts for ﹤0.01% of the portfolio, ranked #3166.

Commonwealth Equity Services first reported a position in AXSM in Q3 2021 and has held it in 12 quarters since. The position peaked at $742K in Q4 2022. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Commonwealth Equity Services held 2,440 shares of Axsome Therapeutics worth $597K as of Q2 2026.
  • Commonwealth Equity Services bought 781 Axsome Therapeutics shares in Q2 2026, an estimated $169K.
  • Axsome Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3166 holding.
  • Commonwealth Equity Services first reported a position in Axsome Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • Commonwealth Equity Services's Axsome Therapeutics position peaked at $742K in Q4 2022.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.